Literature DB >> 12039920

Thalidomide in solid malignancies.

Tim Eisen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12039920     DOI： 10.1200/JCO.2002.20.11.2607

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Resolving a double standard for risk management of thalidomide: an evaluation of two different risk management programmes in Japan.

Authors:  Nobuhiro Ooba; Tsugumichi Sato; Hikaru Watanabe; Kiyoshi Kubota
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

2.  Successful treatment of metastatic hepatic epithelioid hemangioendothelioma with thalidomide: a case report.

Authors:  Claire Raphael; Emma Hudson; Leslie Williams; Jason F Lester; Philip M Savage
Journal:  J Med Case Rep       Date:  2010-12-22

3.  Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers.

Authors:  J B Bartlett; A Michael; I A Clarke; K Dredge; S Nicholson; H Kristeleit; A Polychronis; H Pandha; G W Muller; D I Stirling; J Zeldis; A G Dalgleish
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.